Interferon-γ release assay tests to rule out active tuberculosis [7]

European Respiratory Journal

Volumn 30, Issue 1, 2007, Pages 183-184

  Janssens, J P ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACID FAST BACTERIUM; BACTERIUM IDENTIFICATION; BAYES THEOREM; DIAGNOSTIC VALUE; DISEASE COURSE; FALSE NEGATIVE RESULT; HUMAN; IMMUNOASSAY; INTERFERON GAMMA RELEASE ASSAY TEST; INTERMETHOD COMPARISON; LETTER; LUNG LAVAGE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS;

ADOLESCENT; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERFERON TYPE II; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY;

EID: 34447544551     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00042807     Document Type: Letter

References (11)

1. van Leeuwen RM, Bossink AW, Thijsen SF. Exclusion of active Mycobacterium tuberculosis complex infection with the T-SPOT™.TB assay. Eur Respir J 2007; 29: 605-607.
2. Chapman AL, Munkanta M, Wilkinson KA, et al. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS 2002; 16: 2285-2293.
3. Mayer D. Bayes' theorem and predictive values. In: Essential Evidence-based Medicine. Cambridge, Cambridge University Press, 2004; pp. 222-236.
4. Nendaz MR, Perrier A. [Bayes theorem and likelihood ratios.]. Rev Mal Respir 2004; 21: 394-397.
5. Dye C, Floyd K, Gunneberg C, et al. World Health Organization. Global Tuberculosis Control: Surveillance, Planning, Financing. Geneva, World Health Organization, 2007; p. 277.
6. Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis. Expert Rev Mol Diagn 2006; 6: 413-422.
7. Ferrara G, Losi M, D'Amico R, et al. Use of routine clinical pratice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006; 367: 1328-1334.
8. Dewan PK, Grinsdale J, Kawamura LM. Low sensitivity of a whole-blood interferon-gamma release assay for detection of active tuberculosis. Clin Infect Dis 2007; 44: 69-73.
9. Lee JY, Choi HJ, Park IN, et al. Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J 2006; 28: 24-30.
10. Pai M, Menzies D. Interferon-gamma release assays: what is their role in the diagnosis of active tuberculosis? Clin Infect Dis 2007; 44: 74-77.
11. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005; 54: 49-55.